INTESA SANPAOLO (I07225) 시세

"What is HC Wainwright’s Estimate for AVXL Q1 Earnings?"
MarketBeat News on Feb 21st, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) – Research analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Anavex Life Sciences in a research report

Fannie / Freddie Shorts mounting an early attack - only need

enuf GREEN vol to SEND THEM to the WoodChipper ! - https://investorshub.advfn.com/uimage/uploads/2009/10/15/xmgpqflower2.gif

"Kash Patel confirmed as FBI director"
This is fantastic! The roaches are screaming 🪳

Everyone is well aware of when it’s expected to resume trading.
And when will that be?

Give us a date oh wise one.

I did as well...🥳

IN REGARD TO PRODUCTION: I emailed Ben and asked him what is happening and why we have had no production updates. Here is his response:

I just sent the following to another shareholder, which is based off of a conversation with Jon;[

"What I can tell you is that this ad

Oh wow.  Yugely yuge find.  Pulte on deck nomination hearing February 27.  That's like next week isn't it ?  I lost my calendar.  I have an old one from a few years ago though.  Probably just use that one save some money 

It was a phase 1 trial to test safety.

It was successful as phase 2 has started.

Your lies don't change that.

After tommy and chart flamed out, maybe 9 is the next pumper

I think more surprises coming queenvic. I'm one post also for a very long time here. LOL wear it as a badge of honor. Free speech is a hill worth dying on...these people will find out the hard way, Karma is a b_tch

Lizzy, which filing are you referring to?

Only 1 million shares outstanding at $3.25 now!
Can these CRIMINALS really do another R/S?

..peeps wrong here..positive report, buy-buy-buy GRAB$...

FNMA in PM Bid
$7.61
Ask
$7.48
Bid/Ask Size
25/1

This always makes me laugh...Bid way over the ask but only MMs decide what happens in PM for FNMA

Hope the week ends on a green note here.  

premkt needs a rebound Rally Friday from Thursday's DOW mkt swoon ! -

Level II - moving quickly this am ...https://investorshub.advfn.com/uimage/uploads/2022/8/15/isciz[aoqs126F3A_12.gif

FNMA $7.61 X ($7.48) _ 5,756 volume BID X ASK jumping quickly https://investorshu

It has been a long and difficult 2.5yrs with suicides, depression, divorces… I am grateful and it has been a privilege to fight and represent FTX customers,” he wrote on X.

https://finance.yahoo.com/news/defunct-crypto-exchange-ftx-begins-211838945.html?guccounter=1&guce_referrer=aHR0

Lizzy, the Share Premium Account is Additional Paid-In Capital.

Per UK law, companies choosing to do a share buyback must use funds from profits. If they are NOT profitable (as with Amarin), if they have excess paid-in capital (share premium account), they may cancel that account and

The Water-Less Garden by SGTM: A Game Changer for Dry Climates SGTM's Water-Less Garden is an innovative solution for those living in dry climates or areas with water restrictions. This system uses drought-tolerant plants that require minimal watering, saving water and reducing maintenance costs. Pe

Good morning SGTM

Jeunke, I agree, Lebby with his tiny in-house Device team was trying to accommodate the developments of multiple Tier 1's, "some of the largest Transceiver makers in the world", in putting together custom PIC's for them which was asking way too much in terms of generally assessing the project pieces

Are you referring to the billion dollar news

NKGN...60...🥳...SANTA ANA, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell thera

Rig...Nice news on NKGN...🥳

SANTA ANA, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natur

NKGN...60...🥳...SANTA ANA, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell thera